⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1509693 | 0.79 | — | — | |
| SCHEMBL10436518 | 0.76 | — | — | |
| SCHEMBL11119392 | 0.76 | — | — | |
| SCHEMBL1509703 | 0.76 | — | — | |
| SCHEMBL1492428 | 0.76 | — | — | |
| SCHEMBL795202 | 0.74 | — | — | |
| SCHEMBL28540394 | 0.73 | — | — | |
| SCHEMBL82424 | 0.73 | — | — | |
| SCHEMBL6809738 | 0.73 | — | — | |
| SCHEMBL596147 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11640121-B2 | Carrier for developer and developer | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2023-05-02 | — | — | US | disclosed |
| EP-0458082-B1 | Encapsulated toner compositions | XEROX CORP (US) | 1996-09-04 | — | — | EP | disclosed |
| US-5104763-A | ENCAPSULATED TONER COMPOSITIONS | XEROX CORPORATION (US) | 1992-04-14 | — | — | US | disclosed |
| EP-0458082-A1 | Encapsulated toner compositions | XEROX CORPORATION (US) | 1991-11-27 | — | — | EP | disclosed |
| US-4370326-A | THIAZOLE-SUBSTITUTED | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-01-25 | — | — | US | disclosed |
| EP-0001125-B1 | CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-11-11 | — | — | EP | disclosed |
| EP-0001125-A2 | Cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-03-21 | — | — | EP | disclosed |